People
Antisense drug developer Genta said this week that it has named Per Lindell as vice president of business development.
In this role, Lindell will have "broad responsibility for expanding the company's worldwide business development activities, including partnering negotiations for the company's lead anticancer product, Genasense, as well as in-licensing and acquisition of new products and technology," Genta said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.